Depletion of abundant plasma proteins and limitations of plasma proteomics. - Wikidata - awgldk - TriplyDB

Depletion of abundant plasma proteins and limitations of plasma proteomics.

Depletion of abundant plasma proteins and limitations of plasma proteomics.

http://www.wikidata.org/entity/Q34168719

about

A systematic analysis of eluted fraction of plasma post immunoaffinity depletion: implications in biomarker discovery Sample preparation techniques for the untargeted LC-MS-based discovery of peptides in complex biological matrices Mutant proteins as cancer-specific biomarkers Current perspectives on systems immunology approaches to rheumatic diseases.Mass spectrometry in cancer biomarker research: a case for immunodepletion of abundant blood-derived proteins from clinical tissue specimens Quantitative mass spectrometry analysis using PAcIFIC for the identification of plasma diagnostic biomarkers for abdominal aortic aneurysm A systematic analysis of the effects of increasing degrees of serum immunodepletion in terms of depth of coverage and other key aspects in top-down and bottom-up proteomic analyses Evaluating the effects of preanalytical variables on the stability of the human plasma proteome What was old is new again: using the host response to diagnose infectious disease.Assessment of reproducibility in depletion and enrichment workflows for plasma proteomics using label-free quantitative data-independent LC-MS.Classical MALDI-MS versus CE-based ESI-MS proteomic profiling in urine for clinical applications.Large-scale, ion-current-based proteomics investigation of bronchoalveolar lavage fluid in chronic obstructive pulmonary disease patients Combinatorial peptide ligand library treatment followed by a dual-enzyme, dual-activation approach on a nanoflow liquid chromatography/orbitrap/electron transfer dissociation system for comprehensive analysis of swine plasma proteome.A large, consistent plasma proteomics data set from prospectively collected breast cancer patient and healthy volunteer samples.High Performance IT-MS Sequencing of Glycans (Spatial Resolution of Ovalbumin Isomers).Improvements in proteomic metrics of low abundance proteins through proteome equalization using ProteoMiner prior to MudPIT.Identification of plasma biomarker candidates in glioblastoma using an antibody-array-based proteomic approach A quantitative proteomic approach to identify significantly altered protein networks in the serum of patients with lymphangioleiomyomatosis (LAM).Global proteomics and metabolomics in cancer biomarker discovery."The quest for biomarkers": are we on the right technical track?Discovery proteomics and nonparametric modeling pipeline in the development of a candidate biomarker panel for dengue hemorrhagic fever.Performance of different separation methods interfaced in the same MS-reflection TOF detector: a comparison of performance between CE versus HPLC for biomarker analysis.Proteomic biomarkers predicting lymph node involvement in serum of cervical cancer patients. Limitations of SELDI-TOF MS.Reproducible quantification of cancer-associated proteins in body fluids using targeted proteomics.Microscale depletion of high abundance proteins in human biofluids using IgY14 immunoaffinity resin: analysis of human plasma and cerebrospinal fluid.Online monitoring of immunoaffinity-based depletion of high-abundance blood proteins by UV spectrophotometry using enhanced green fluorescence protein and FITC-labeled human serum albumin.Protein analysis by shotgun/bottom-up proteomics Complete amino acid sequencing and immunoaffinity clean-up can facilitate screening of various chemical modifications on human serum albumin.Protein alterations associated with pancreatic cancer and chronic pancreatitis found in human plasma using global quantitative proteomics profiling.Deeper insight into chronic kidney disease-related atherosclerosis: comparative proteomic studies of blood plasma using 2DE and mass spectrometry.In vivo assessment of protease dynamics in cutaneous wound healing by degradomics analysis of porcine wound exudates.A sarabande of tropical fruit proteomics: Avocado, banana, and mango.IgY14 and SuperMix immunoaffinity separations coupled with liquid chromatography-mass spectrometry for human plasma proteomics biomarker discovery.Comparison of Depletion Strategies for the Enrichment of Low-Abundance Proteins in Urine.A xenograft mouse model coupled with in-depth plasma proteome analysis facilitates identification of novel serum biomarkers for human ovarian cancer Relative quantification of serum proteins from pancreatic ductal adenocarcinoma patients by stable isotope dilution liquid chromatography-mass spectrometry.Identification of potential breast cancer markers in nipple discharge by protein profile analysis using two-dimensional nano-liquid chromatography/nanoelectrospray ionization-mass spectrometry.Advancing the sensitivity of selected reaction monitoring-based targeted quantitative proteomics.PNGase F catalyzes de-N-glycosylation in a domestic microwave The Clinical Significance of Glycoprotein Phospholipase D Levels in Distinguishing Early Stage Latent Autoimmune Diabetes in Adults and Type 2 Diabetes.

P2860

Q21135230-8A2E50EB-AB40-4973-B00A-0748DB7049DE Q21296806-A2E6CAB7-76EE-4655-9646-09769731C097 Q24625180-DE2FBB4D-0B18-4989-8570-ABC87BDD7D3C Q27687400-9E90AC59-790D-464B-BDEF-0C43FBD24C1D Q28307595-3F6E8375-2F1D-44C9-94D3-63935B449D60 Q28478305-5A4BCACB-233A-4379-848D-04CF145DA2BC Q28732696-468B0484-0725-4BAA-AD29-E52FEB79D939 Q30372676-9358E161-7604-40CF-9B3C-B248E498D4CD Q30376327-2A2CDB26-D75A-4A77-ABFF-6A9B2888D3A9 Q30685445-5EA44D00-D432-442B-9839-95726D7B358A Q31148183-74202B01-730B-4B30-9293-A4449692730E Q33815640-FB7C9C55-DC73-481F-90F9-9D4C12BD7766 Q33872613-CA41830E-8816-4BEE-A064-EE48FE2153BB Q33914424-94A1345B-35AB-466A-8B8C-2CFEBD5D485E Q33936469-5ABC2923-E169-4937-9DB1-955D9133C60E Q33942198-CED099AD-948D-408B-8A3C-76450CE3D990 Q33946339-18288096-715C-4C39-AA56-64825C4747EF Q34061748-2C1E2852-8585-4438-83FB-6A3BE71BC423 Q34079038-CF69BFE3-472A-4C4E-9A6C-88DA31DE07C6 Q34116103-98B4677E-C621-42B6-9EBA-355024E42ECC Q34178965-F85A6394-9CE6-430C-9DC2-88A16693C3F4 Q34208587-B13B5CB5-B274-4605-9D00-83B3133C659B Q34302950-E1E3E5EA-9A23-4451-8750-F1E8C3CB72B6 Q34333925-D1FC4DD2-71E7-4CE6-9A13-37313452BA65 Q34401658-DF677727-7CC9-4794-B9C1-693F6887BC43 Q34448010-FF4B78C6-1F25-4B87-A7A1-EE474C7BF056 Q34600986-E4D37A9D-342B-41B8-BE7B-51FE7173ECE4 Q34813647-9C37A3C5-81C1-4EAF-9A40-AF5F1C152EFD Q34958895-DE524788-9B51-4D2D-A166-83D9F78CA026 Q35047636-5358695C-E3CE-4F23-BDA9-F5AA8BFAADEA Q35148563-FF1D2D8C-DBA8-4537-A3C2-383CC551B551 Q35491630-F56BEA78-C6F5-4508-B05B-D253E84956A4 Q35680919-0D344CAF-5818-401B-A8E2-D4C516728013 Q35712111-D8A489D8-BEA4-4B46-9B9E-78C6CCD51238 Q35736782-F16B8945-7964-4AC1-91CA-07E72B5A2DE9 Q35798915-CF9E9B8C-9D3A-4449-9872-6EBF5A2584B3 Q35955117-5FF5945C-39F3-4725-A135-01E40501D17C Q36031629-2CCB8BFB-6A49-40A2-8BD5-5154D7CE5D3E Q36060522-8887ECEC-61A0-4164-9C3F-05F441B3C091 Q36062980-0A278B43-F722-4B9A-A892-C9D7D5853028

P2860

Depletion of abundant plasma proteins and limitations of plasma proteomics.

http://www.wikidata.org/entity/Q34168719

description

2010 nî lūn-bûn

@nan

2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Depletion of abundant plasma proteins and limitations of plasma proteomics.

@ast

Depletion of abundant plasma proteins and limitations of plasma proteomics.

@en

Depletion of abundant plasma proteins and limitations of plasma proteomics.

@nl

type

label

Depletion of abundant plasma proteins and limitations of plasma proteomics.

@ast

Depletion of abundant plasma proteins and limitations of plasma proteomics.

@en

Depletion of abundant plasma proteins and limitations of plasma proteomics.

@nl

prefLabel

Depletion of abundant plasma proteins and limitations of plasma proteomics.

@ast

Depletion of abundant plasma proteins and limitations of plasma proteomics.

@en

Depletion of abundant plasma proteins and limitations of plasma proteomics.

@nl

P1433

Q34168719-A67E9E99-C542-403B-A550-2A95C67B0518

P1476

Q34168719-8783C7A2-5E2E-44A7-A01E-19EC28660CAD

P2093

Q34168719-26AD8FE1-E2A0-43FC-BC38-0C2970BB4FAB

Q34168719-4E50B9C6-141E-4D2B-A7AF-EAEAB31F8978

Q34168719-5933D379-E63A-4D6A-984F-A58B9888BAC9

Q34168719-F1C4A8C3-83AC-46F5-9031-4B61F579B15B

Q34168719-F649237E-580A-4731-983B-E2F1F21199A6

P2860

Q34168719-03DDAEA6-BC4E-4297-BD87-382BBBAF8D3E

Q34168719-1E08B360-0B17-4998-9447-956070D1A5AC

Q34168719-28BA35C4-82B5-4EBC-A8C2-9368062F418A

Q34168719-30AD3305-EF96-401A-BA03-477442F38C2E

Q34168719-4250B9E1-A6A2-4EA7-B67F-C4D9AB4C3632

Q34168719-45CE1275-BFB1-48BC-A5D5-EDB9FF028992

Q34168719-497B9A71-CDAB-4984-8290-47FBBF36B248

Q34168719-4C564CE2-0FD4-4F71-905C-E7951FE33626

Q34168719-4D0BF387-6C1F-4F9F-81ED-F9C00EF7434E

Q34168719-54C66FE0-EF50-4ACF-911E-9A84999C3E01

P304

Q34168719-CF561924-14DB-4EB1-A6DD-247E6B9F7E4A

P31

Q34168719-2CED1F43-A7A2-4863-9132-A281B987D6D8

P356

Q34168719-33420F28-78A6-4F94-B102-CC0F26E76D69

P433

Q34168719-F533887E-A2D9-4FB5-8F56-A6C3BED78C7E

P478

Q34168719-56F6D12E-65B3-4412-A5B9-551FC6D32E39

P50

Q34168719-3CEC0667-4432-411C-BD7B-8F9B697D8D9E

Q34168719-E2A70659-DE75-489B-BFDD-31EA987696D8

P577

Q34168719-E6F1DFA3-6CCA-48FC-A3F6-5087A736EE8E

P5875

Q34168719-8FE9AC53-8F0A-4592-90B8-ABDC0C6E864C

P698

Q34168719-4831B949-85EE-4980-BB0F-E75A29F58CBA

P932

Q34168719-8AF82B74-1FE8-43C5-A830-AA46823DBD16

P356

P1433

Journal of Proteome Research

P1476

Depletion of abundant plasma proteins and limitations of plasma proteomics

@en

P2093

Kristin L Cheek

http://www.w3.org/2001/XMLSchema#string

Misti Y Martinez

http://www.w3.org/2001/XMLSchema#string

Paul A Rudnick

http://www.w3.org/2001/XMLSchema#string

Robbert J C Slebos

http://www.w3.org/2001/XMLSchema#string

Stephen E Stein

http://www.w3.org/2001/XMLSchema#string

P2860

An investigation into the human serum "interactome"

MyriMatch: highly accurate tandem mass spectral peptide identification by multivariate hypergeometric analysis

Hydrophobic ligand binding by Zn-alpha 2-glycoprotein, a soluble fat-depleting factor related to major histocompatibility complex proteins

The human plasma proteome: history, character, and diagnostic prospects

Binding of transforming growth factor-beta (TGF-beta) to pregnancy zone protein (PZP). Comparison to the TGF-beta-alpha 2-macroglobulin interaction

A model for random sampling and estimation of relative protein abundance in shotgun proteomics

Universal sample preparation method for proteome analysis

Challenges in deriving high-confidence protein identifications from data gathered by a HUPO plasma proteome collaborative study.

Multi-component immunoaffinity subtraction chromatography: an innovative step towards a comprehensive survey of the human plasma proteome.

Depletion of one, six, twelve or twenty major blood proteins before proteomic analysis: the more the better?

P304

4982-4991

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/PR100646W

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

Daniel C. Liebler

P577

2010-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45460008

http://www.w3.org/2001/XMLSchema#string

P698

20677825

http://www.w3.org/2001/XMLSchema#string

P932

2948641

http://www.w3.org/2001/XMLSchema#string